The Cardio IQ Advanced Lipid Panel is an advanced cardiovascular diagnostic test that uses spectroscopy to uniquely provide rapid, simultaneous and direct measurement of LDL particle number and size of LDL particles, as well as direct measurement of HDL and VLDL subclasses. This detailed lipoprotein particle information allows clinicians to make more effective individualized treatment decisions than previously possible based on standard lipid panel testing. The atherosclerotic culprit is LDL particle number, not LDL cholesterol.
Why should I use the Cardio IQ Advanced Lipid Panel?
You should use the Cardio IQ test because it provides a more accurate picture of cardiovascular (CVD) risk than the standard lipid panel. Each year, heart attacks kill more than 8 times as many women than breast cancer and 15 times as many men than prostate cancer. According to a major study, 50% of the people who suffered a heart attack had normal cholesterol levels. If your cholesterol is normal, being lowered by treatments like diet, exercise, or medication; or you have any of the conditions listed below, the Cardio IQ Panel may be right for you:
- Previous heart attack
- Family history of heart attack
- High blood pressure
- Cardiometabolic risk
- Metabolic syndrome
- Low HDL (dyslipidemia)
- High triglycerides
The Cardio IQ Advanced Lipid Panel includes:
- Total Cholesterol, Triglycerides, HDL, LDL and Cholesterol/HDL ratio
- LDL Particle Number
- LDL Peak Size
- LDL Pattern
- HDL Large
- LDL Small
- LDL Medium
- Apolipoprotein B
- Lipoprotein (a)
It is recommended to fast for 12-14 hours before getting your blood drawn for this test.
The Cardio IQ® Report provides an in-depth assessment of cardiovascular risks to help physicians recommend the ideal individualized treatment option for patient to minimize cardiovascular disease.
The report is simple, yet comprehensive. It is color-coded to display progressive risk values versus goal using “optimal,” “moderate,” and “high-risk” categories and grouped by functional categories.
This advanced test uses a technology called Ion mobility. This test goes far beyond your basic lipid test, for starters this test helps to reclassify a patient’s cardiovascular risk. Nearly half of all heart attack patients were found to have no prior risk which would indicate they were heading toward an attack. Cardio IQ Ion Mobility tests directly detects, measures and quantifies the number and size of all lipoprotein subfractions. Knowing what particles make up your LDL and HDL cholesterol may be important. Ion Mobility Technology provides subclass separation that will allow your healthcare provider to identify your cardiovascular risk over time. Following the change in your lipid profile as you respond to diet, exercise and possible medication to reduce your cardiovascular risk is important. Ion Mobility provides the opportunity to determine if treatment is working and if not, optimize the aggressiveness of therapy to hopefully make a difference that can be seen in the Ion Mobility measurement and graphical representation of your LDL and HDL particles.
Ion mobility technology precisely quantifies lipoprotein fractions across the entire lipoprotein spectrum; this comprises very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) particles. Ion mobility identifies 2 main subclasses of HDL: large HDL and small HDL. The antioxidant properties of large HDL may help protect the arterial wall. A decreased large HDL subclass has historically suggested increased CVD risk.
An elevated total LDL particle number is associated with a 1.2 to 1.4-fold increase in cardiovascular disease risk. Similarly, elevated small and medium LDL particle numbers have been associated with a 1.2 to 1.4-fold increase.